106 related articles for article (PubMed ID: 8971178)
1. Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma.
Jürgens B; Schmitz-Dräger BJ; Schulz WA
Cancer Res; 1996 Dec; 56(24):5698-703. PubMed ID: 8971178
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas.
Florl AR; Löwer R; Schmitz-Dräger BJ; Schulz WA
Br J Cancer; 1999 Jul; 80(9):1312-21. PubMed ID: 10424731
[TBL] [Abstract][Full Text] [Related]
3. Abnormal methylation of the calcitonin gene in human colonic neoplasms.
Silverman AL; Park JG; Hamilton SR; Gazdar AF; Luk GD; Baylin SB
Cancer Res; 1989 Jul; 49(13):3468-73. PubMed ID: 2731168
[TBL] [Abstract][Full Text] [Related]
4. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
[TBL] [Abstract][Full Text] [Related]
5. Hypomethylation of cytosine 5-methyltransferase in human neoplasms.
Butler TL; Kay PH; Jacobsen PF
Anticancer Res; 2000; 20(3A):1435-8. PubMed ID: 10928053
[TBL] [Abstract][Full Text] [Related]
6. DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis.
Nakagawa T; Kanai Y; Ushijima S; Kitamura T; Kakizoe T; Hirohashi S
J Urol; 2005 May; 173(5):1767-71. PubMed ID: 15821584
[TBL] [Abstract][Full Text] [Related]
7. DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma.
Boireau S; Buchert M; Samuel MS; Pannequin J; Ryan JL; Choquet A; Chapuis H; Rebillard X; Avancès C; Ernst M; Joubert D; Mottet N; Hollande F
Carcinogenesis; 2007 Feb; 28(2):246-58. PubMed ID: 16829686
[TBL] [Abstract][Full Text] [Related]
8. p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours.
Le Frère-Belda MA; Cappellen D; Daher A; Gil-Diez-de-Medina S; Besse F; Abbou CC; Thiery JP; Zafrani ES; Chopin DK; Radvanyi F
Br J Cancer; 2001 Nov; 85(10):1515-21. PubMed ID: 11720438
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
Dhawan D; Hamdy FC; Rehman I; Patterson J; Cross SS; Feeley KM; Stephenson Y; Meuth M; Catto JW
J Pathol; 2006 Jul; 209(3):336-43. PubMed ID: 16639696
[TBL] [Abstract][Full Text] [Related]
10. Global and gene-specific epigenetic patterns in human bladder cancer genomes are relatively stable in vivo and in vitro over time.
Markl ID; Cheng J; Liang G; Shibata D; Laird PW; Jones PA
Cancer Res; 2001 Aug; 61(15):5875-84. PubMed ID: 11479229
[TBL] [Abstract][Full Text] [Related]
11. Chemically induced DNA hypomethylation in breast carcinoma cells detected by the amplification of intermethylated sites.
Sadikovic B; Haines TR; Butcher DT; Rodenhiser DI
Breast Cancer Res; 2004; 6(4):R329-37. PubMed ID: 15217500
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas.
Baylin SB; Höppener JW; de Bustros A; Steenbergh PH; Lips CJ; Nelkin BD
Cancer Res; 1986 Jun; 46(6):2917-22. PubMed ID: 3009002
[TBL] [Abstract][Full Text] [Related]
13. The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells.
Liang G; Robertson KD; Talmadge C; Sumegi J; Jones PA
Cancer Res; 2000 Sep; 60(17):4907-12. PubMed ID: 10987305
[TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
15. DNA hypomethylation on pericentromeric satellite regions significantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas.
Nakagawa T; Kanai Y; Ushijima S; Kitamura T; Kakizoe T; Hirohashi S
J Urol; 2005 Jan; 173(1):243-6. PubMed ID: 15592089
[TBL] [Abstract][Full Text] [Related]
16. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.
Kim WJ; Kim EJ; Jeong P; Quan C; Kim J; Li QL; Yang JO; Ito Y; Bae SC
Cancer Res; 2005 Oct; 65(20):9347-54. PubMed ID: 16230397
[TBL] [Abstract][Full Text] [Related]
17. Human breast and colon cancers exhibit alterations of DNA methylation patterns at several DNA segments on chromosomes 11p and 17p.
Ribieras S; Song-Wang XG; Martin V; Lointier P; Frappart L; Dante R
J Cell Biochem; 1994 Sep; 56(1):86-96. PubMed ID: 7806594
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR.
Gonzalgo ML; Liang G; Spruck CH; Zingg JM; Rideout WM; Jones PA
Cancer Res; 1997 Feb; 57(4):594-9. PubMed ID: 9044832
[TBL] [Abstract][Full Text] [Related]
19. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
20. In situ detection of global DNA hypomethylation in exfoliative urine cytology of patients with suspected bladder cancer.
Seifert HH; Schmiemann V; Mueller M; Kazimirek M; Onofre F; Neuhausen A; Florl AR; Ackermann R; Boecking A; Schulz WA; Grote HJ
Exp Mol Pathol; 2007 Jun; 82(3):292-7. PubMed ID: 17026997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]